361 related articles for article (PubMed ID: 28432847)
21. Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review.
Casey RT; Warren AY; Martin JE; Challis BG; Rattenberry E; Whitworth J; Andrews KA; Roberts T; Clark GR; West H; Smith PS; Docquier FM; Rodger F; Murray V; Simpson HL; Wallis Y; Giger O; Tran M; Tomkins S; Stewart GD; Park SM; Woodward ER; Maher ER
J Clin Endocrinol Metab; 2017 Nov; 102(11):4013-4022. PubMed ID: 28973655
[TBL] [Abstract][Full Text] [Related]
22. Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes.
Pęczkowska M; Kowalska A; Sygut J; Waligórski D; Malinoc A; Janaszek-Sitkowska H; Prejbisz A; Januszewicz A; Neumann HP
Clin Endocrinol (Oxf); 2013 Dec; 79(6):817-23. PubMed ID: 23551045
[TBL] [Abstract][Full Text] [Related]
23. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.
Jochmanova I; Wolf KI; King KS; Nambuba J; Wesley R; Martucci V; Raygada M; Adams KT; Prodanov T; Fojo AT; Lazurova I; Pacak K
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1421-1435. PubMed ID: 28374168
[TBL] [Abstract][Full Text] [Related]
24. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP
Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557
[TBL] [Abstract][Full Text] [Related]
25. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.
de Cubas AA; Leandro-García LJ; Schiavi F; Mancikova V; Comino-Méndez I; Inglada-Pérez L; Perez-Martinez M; Ibarz N; Ximénez-Embún P; López-Jiménez E; Maliszewska A; Letón R; Gómez Graña A; Bernal C; Alvarez-Escolá C; Rodríguez-Antona C; Opocher G; Muñoz J; Megias D; Cascón A; Robledo M
Endocr Relat Cancer; 2013 Aug; 20(4):477-93. PubMed ID: 23660872
[TBL] [Abstract][Full Text] [Related]
26. Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.
Rajan S; Zaidi G; Agarwal G; Mishra A; Agarwal A; Mishra SK; Bhatia E
World J Surg; 2016 Mar; 40(3):690-6. PubMed ID: 26438242
[TBL] [Abstract][Full Text] [Related]
27. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498
[TBL] [Abstract][Full Text] [Related]
28. Pheochromocytoma and paraganglioma: implications of germline mutation investigation for treatment, screening, and surveillance.
Gómez AM; Soares DC; Costa AAB; Pereira DP; Achatz MI; Formiga MN
Arch Endocrinol Metab; 2019 Jul; 63(4):369-375. PubMed ID: 31365623
[TBL] [Abstract][Full Text] [Related]
29. Pediatric paraganglioma: an early manifestation of an adult disease secondary to germline mutations.
Mora J; Cascón A; Robledo M; Catala A
Pediatr Blood Cancer; 2006 Nov; 47(6):785-9. PubMed ID: 16304664
[TBL] [Abstract][Full Text] [Related]
30. Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma.
Cascón A; López-Jiménez E; Landa I; Leskelä S; Leandro-García LJ; Maliszewska A; Letón R; de la Vega L; García-Barcina MJ; Sanabria C; Alvarez-Escolá C; Rodríguez-Antona C; Robledo M
Horm Metab Res; 2009 Sep; 41(9):672-5. PubMed ID: 19343621
[TBL] [Abstract][Full Text] [Related]
31. Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing.
Fishbein L; Merrill S; Fraker DL; Cohen DL; Nathanson KL
Ann Surg Oncol; 2013 May; 20(5):1444-50. PubMed ID: 23512077
[TBL] [Abstract][Full Text] [Related]
32. Genotype-phenotype correlations in paediatric and adolescent phaeochromocytoma and paraganglioma: a cross-sectional study.
Seabrook A; Vasudevan A; Neville K; Gerstl B; Benn D; Smith J; Kirk J; Gill A; Clifton-Bligh R; Tucker K
Arch Dis Child; 2024 Feb; 109(3):201-208. PubMed ID: 38071512
[TBL] [Abstract][Full Text] [Related]
33. The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes.
Udager AM; Magers MJ; Goerke DM; Vinco ML; Siddiqui J; Cao X; Lucas DR; Myers JL; Chinnaiyan AM; McHugh JB; Giordano TJ; Else T; Mehra R
Hum Pathol; 2018 Jan; 71():47-54. PubMed ID: 29079178
[TBL] [Abstract][Full Text] [Related]
34. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.
Castro-Vega LJ; Buffet A; De Cubas AA; Cascón A; Menara M; Khalifa E; Amar L; Azriel S; Bourdeau I; Chabre O; Currás-Freixes M; Franco-Vidal V; Guillaud-Bataille M; Simian C; Morin A; Letón R; Gómez-Graña A; Pollard PJ; Rustin P; Robledo M; Favier J; Gimenez-Roqueplo AP
Hum Mol Genet; 2014 May; 23(9):2440-6. PubMed ID: 24334767
[TBL] [Abstract][Full Text] [Related]
35. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of Succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes.
Pai R; Manipadam MT; Singh P; Ebenazer A; Samuel P; Rajaratnam S
APMIS; 2014 Nov; 122(11):1130-5. PubMed ID: 24735130
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.
Dénes J; Swords F; Rattenberry E; Stals K; Owens M; Cranston T; Xekouki P; Moran L; Kumar A; Wassif C; Fersht N; Baldeweg SE; Morris D; Lightman S; Agha A; Rees A; Grieve J; Powell M; Boguszewski CL; Dutta P; Thakker RV; Srirangalingam U; Thompson CJ; Druce M; Higham C; Davis J; Eeles R; Stevenson M; O'Sullivan B; Taniere P; Skordilis K; Gabrovska P; Barlier A; Webb SM; Aulinas A; Drake WM; Bevan JS; Preda C; Dalantaeva N; Ribeiro-Oliveira A; Garcia IT; Yordanova G; Iotova V; Evanson J; Grossman AB; Trouillas J; Ellard S; Stratakis CA; Maher ER; Roncaroli F; Korbonits M
J Clin Endocrinol Metab; 2015 Mar; 100(3):E531-41. PubMed ID: 25494863
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation.
Kamai T; Murakami S; Arai K; Nishihara D; Uematsu T; Ishida K; Kijima T
BMC Cancer; 2022 Mar; 22(1):289. PubMed ID: 35300626
[TBL] [Abstract][Full Text] [Related]
39. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.
Burnichon N; Cascón A; Schiavi F; Morales NP; Comino-Méndez I; Abermil N; Inglada-Pérez L; de Cubas AA; Amar L; Barontini M; de Quirós SB; Bertherat J; Bignon YJ; Blok MJ; Bobisse S; Borrego S; Castellano M; Chanson P; Chiara MD; Corssmit EP; Giacchè M; de Krijger RR; Ercolino T; Girerd X; Gómez-García EB; Gómez-Graña A; Guilhem I; Hes FJ; Honrado E; Korpershoek E; Lenders JW; Letón R; Mensenkamp AR; Merlo A; Mori L; Murat A; Pierre P; Plouin PF; Prodanov T; Quesada-Charneco M; Qin N; Rapizzi E; Raymond V; Reisch N; Roncador G; Ruiz-Ferrer M; Schillo F; Stegmann AP; Suarez C; Taschin E; Timmers HJ; Tops CM; Urioste M; Beuschlein F; Pacak K; Mannelli M; Dahia PL; Opocher G; Eisenhofer G; Gimenez-Roqueplo AP; Robledo M
Clin Cancer Res; 2012 May; 18(10):2828-37. PubMed ID: 22452945
[TBL] [Abstract][Full Text] [Related]
40. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
